Funder: Ohio State University
Due Dates: August 31, 2026 (Fall 2026 application) | January 29, 2027 (Spring 2027 application)
Funding Amounts: Fall 2026: $75,000 per year for two years
Summary: Seed funding for Ohio State investigator-initiated cancer clinical trials that generate preliminary data and publications for external funding.
Key Information: Principal investigators must participate in Pelotonia and raise at least $1,250, subject to stated exceptions.
Description
The Ohio State University Comprehensive Cancer Center – James (OSUCCC – James) offers Clinical Trial Grants and Protocol-Specific Research Support through its Intramural Research Program (IRP), supported by Pelotonia and/or Cancer Center Support Grant funding. The program provides seed support for investigator-initiated phase I and pilot clinical trials exploring novel concepts in cancer prevention and treatment.
The awards help Ohio State cancer researchers generate preliminary data and scientific publications needed to compete for external research support, particularly from the National Cancer Institute (NCI). Preference is given to trials translating Ohio State basic science into the clinic. Funding priorities include scientific merit, innovation, interdisciplinary collaboration, potential impact on cancer treatment, and contribution to the OSUCCC – James mission.
